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ABSTRACT 
 
 Shape memory polymer (SMP) foams have been developed for various embolic 
applications. These polyurethane materials can be deformed and stored in a 
secondary shape, from which they can recover their primary shape after exposure to 
an external stimulus, such as heat and moisture. Tailored actuation temperatures of 
SMPs provide benefits for minimally invasive biomedical applications, but incur 
significant challenges for SMP-based medical device sterilization. Most sterilization 
methods require high temperature and/or humidity to effectively reduce the 
bioburden of the device, but the environment must be tightly controlled after device 
fabrication.  
 Here, three probable sterilization methods: non-traditional ethylene oxide 
(ntEtO) gas sterilization gamma irradiation, and electron beam (ebeam) irradiation 
were investigated for SMP-based embolic medical devices. SMP foam was tested for 
changes in thermal properties using differential scanning calorimetry. Mechanical 
testing was used to analyze sterilization-induced material changes. Unconstrained 
expansion profiles were obtained to see if sterilization affected the shape memory 
properties of the foam. Finally, spectroscopy was done to analyze potential molecular 
changes in the foams.  
 Thermal characterization of the sterilized foams indicated that ntEtO gas 
sterilization decreased the glass transition temperature. Gamma irradiation was 
hypothesized to generate oxidative radicals that threaten the biostability of the 
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embolic medical device. Further material characterization was undertaken on the 
ebeam sterilized samples, which indicated minimal changes to foam integrity and 
device functionality. 
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NOMENCLATURE 
 
SMP Shape memory polymer 
Ttrans Transition temperature 
SME Shape memory effect 
Tm Melt transition temperature 
Tg Glass transition temperature 
BDL Biomedical Device Lab 
NED Neurovascular embolization device 
Nitinol Nickel-titanium alloy 
PED Peripheral embolization device 
AVM Arteriovenous malformations 
ntEtO Non-traditional ethylene oxide 
Ebeam Electron beam radiation 
EtO Ethylene Oxide 
HPED N,N,N’,N’-tetrakis(2-hydroxypropyl)ethylenediamine 
TEA Triethanolamine 
TMHDI Trimethyl-1,6-hexamethylene diisocyanate 
HDI Hexamethylene diisocyanate 
IPA 2-propanol 
DI Deionized water 
NCO Isocyanate  
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OH Hydroxyl 
RO Reverse Osmosis 
DSC Differential scanning calorimetry 
UTS Ultimate tensile stress 
FTIR Fourier transform infrared spectroscopy 
DMA Dynamic mechanical analysis 
ATR Attenuated total reflectance 
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CHAPTER I  
INTRODUCTION1  
 
1.1. Shape memory polymer (SMP) foams 
Recent advances in material science have increased the use of polymers for 
biomedical applications [1] [3]. Stimuli responsive polymers, such as shape memory 
polymers (SMPs), have shown promise in polymer-based medical devices, including 
thrombus removal devices, cardiac valve repair devices, and various embolic devices[1] 
[4] [5] [6] [7]. SMPs are a class of smart material that are capable of being deformed and 
stored in a stable secondary shape and recovering to a primary form when exposed to a 
stimulus, such as heat (Figure 1.1) [4] [5] [8] [9]. Thermal SMPs are synthesized into 
their primary shape, which is fixed by crosslinking. The secondary shape is set via 
polymer deformation above its Ttrans, and subsequent cooling back to its glassy state 
(below Ttrans) while maintaining the deformation [1]. Upon supplying sufficient thermal 
energy to the polymer system, entropic potential drives the shape recovery of the 
polymer from its secondary state to its primary shape [1].  
                                                
1 Parts of this chapter are from “Effects	of	Sterilization	on	Shape	Memory	Polyurethane	Embolic	Foam	Devices”	by	R.	Muschalek,	Nash	L.D.,	Jones	R,	Hasan	S.M.,	Keller	B.K.,	Monroe	M.B.,	Maitland	D.J., which is under review by the Journal of Medical Devices.  
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Figure 1.1: Shape memory effect (SME) of a thermally actuated SMP. SMPs can be fixed into a 
secondary shape by heating above its Ttrans and applying a mechanical force to deform the polymer 
into the desired secondary shape. Cooling the polymer below its Ttrans while maintaining the 
mechanical deformation will set the secondary shape. Upon heating the SMP above its Ttrans, the 
polymer will recover to its primary shape.  
 
 
SMPs are networks of switching segments and net points, where the net points 
determine the primary shape of the polymer and the switching segments allow 
deformation above Ttrans by absorbing stress on the system. Predominantly crystalline 
SMPs have a Ttrans equal to their melt transition temperature (Tm), and predominantly 
amorphous materials exhibit a Ttrans equivalent to their glass transition temperature (Tg) 
[1].  
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Figure 1.2: SME for an amorphous polymer system. The Ttrans for this system is the Tg of the SMP. 
The netpoints of the amorphous polymer will determine the primary shape, while the switching 
segments allow for the SME. Reprinted with permission from Lendlein et. al. [1].  
 
 
The SMPs used in this work are polyurethane SMP foams, which are synthesized 
as highly crosslinked amorphous polymers (Figure 1.2). This shape memory property 
allows for non-invasive or minimally-invasive implantable medical devices, as SMPs 
can be stored in a compressed form during delivery through a catheter, after which they 
expand to their primary shape upon heating to body temperature [4, 8, 9] [10] [11]. 
Additionally, these polymers are highly biocompatible, highly thrombogenic, exhibit 
tunable glass transition temperatures (-100 °C to 80 °C), ultra low densities (0.008 
g/cm3), high porosities (98%), and X- ray visibility, which makes them ideal candidates 
for a wide range of medical devices, including aneurysm treatment [5] [9] [12] [13] [14].  
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An aneurysm is a weakening of the vascular wall that allows localized dilation 
and ballooning of the artery [15]. Aneurysms may be congenital or caused by defects in 
the vascular wall, such as atherosclerotic plaques [15] [16]. Additional risk factors, 
including hypertension and connective tissue disorders, have also been identified.  
Aneurysms may occur in many sites in the body, but are most commonly found 
in the peripheral vasculature (including the aorta, mesenteric arteries and splenic 
arteries) or cerebral arteries. Aneurysms are susceptible to rupturing due to wall 
thinning, which causes a subarachnoid hemorrhage (SAH) if aneurysm is located 
intracranially or internal bleeding if aneurysm is located peripherally. The Biomedical 
Device Lab (BDL) at Texas A&M has developed two shape memory polyurethane 
embolic foam devices for treatment of both intracranial aneurysms and occlusion of the 
peripheral vasculature for various malformations.  
 
1.2. Neurovascular embolization for treatment of intracranial aneurysms 
Most neurovascular aneurysms are spherical outpouchings, or saccular 
aneurysms, that range from 2-50 mm in diameter, with an average of 8 mm [17]. They 
are most commonly observed at the apex of the subarachnoid arterial bifurcations [18]. 
It is estimated that 30,000 intracranial aneurysms rupture in the United States 
every year, and approximately 3-5 million Americans have or will develop an 
intracranial saccular aneurysm in their lifetime [15] [19]. If an aneurysm ruptures to 
cause a SAH, there is a reduction in cerebral blood flow, reduced cerebral 
autoregulation, an increase in intracranial pressure, and acute vasoconstriction, all of 
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which pose significant danger to the viability of the cerebral tissue [20]. It is estimated 
that only half of patients will survive a SAH, and there is substantial morbidity among 
survivors [20] . Currently available treatments for intracranial aneurysms include 
surgical clipping and endovascular coiling, as well as the proposed device from the BDL 
(Figure 1.3 A-C). 
 
 
A) Surgical Clipping B) Endovascular Coiling C) SMP Foam Device 
 
 
 
Figure 1.3: Currently available treatments for cerebral aneurysms and the proposed SMP device. A) 
Surgical clipping [21], B) Endovascular coiling [22], and C) SMP foam device that expands upon 
implantation and acts as a scaffold for cellular infiltration 
 
 
 
Aneurysm clipping requires a high-risk, invasive surgery to implant a metal clip 
at the base of the aneurysm to prevent blood flow into the aneurysm sac and close off the 
aneurysm neck (Figure 1.3 A) [23]. Depending on the aneurysm location, size and neck 
geometry, a surgeon may not be able to safely clip the aneurysm [24]. Additionally, as 
with any invasive procedure, there is a longer recovery time and the possibility of 
infection [24].  
Endovascular coiling (Figure 1.3 B) provides a minimally invasive approach to 
aneurysm treatment that aims to fill the aneurysm sac with materials (primarily soft 
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platinum coils) to reduce the risk of rupture or re-bleeding [24]. This approach allows for 
better access to the tortuous vasculature, because coils are delivered through a 
microcatheter to the aneurysm sac with the aid of fluoroscopy imaging [25]. However, a 
ten-year retrospective review of aneurysm coiling patients found that 24.5% of patients 
experienced recanalization and approximately 5% required additional treatment [25]. In 
addition to high rates of recanalization, these devices are also plagued by chronic 
inflammation [26] and low occlusion rates (23-37%) [27] [28]. Polymer coated coils 
were introduced to address some of these issues, which showed promising results 
initially; however, as the polymer was resorbed by the body, recanalization occurred 
[29].  
Polyurethane SMP foams have been incorporated into a neurovascular 
embolization device (NED) and have shown excellent embolic and healing responses 
[14] [30] (Figure 1.3 C). The SMP foam is threaded over a core of platinum wound 
nickel-titanium (nitinol) [11], which makes these devices well suited for clinical 
adoption due to the similarity to existing devices. SMP devices passively actuate at body 
temperature (37°C), can be delivered non-invasively through a microcatheter, and detach 
via a similar mechanism to current coil devices [31].  
 
1.3 Peripheral embolization device (PED) for various malformations  
In certain conditions, physicians utilize embolization devices to divert blood flow 
from a region outside the vasculature of the brain. As with cerebral aneurysms, 
embolization is a technique that is often utilized instead of an invasive surgery to block 
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blood flow to specific anatomies. This treatment can be used to address a variety of 
morbidities, such as arteriovenous malformations (AVM), venous insufficiency, patent 
foramen ovales, or traumatic internal bleeding [32] Polyurethane SMP foams show 
promise for complete occlusion with a single device for any of the aforementioned 
conditions [4, 33] [32]. SMP-based PEDs also contain a platinum/ iridium alloy anchor 
coil and marker band for device visualization under fluoroscopy [32].   
 
 
 
Figure 1.4: PED for occlusion of various morbidities in the peripheral vasculature. Devices contain a 
platinum/ iridium alloy marker band and anchor coil for visualization and SMP foam for rapid and 
complete vessel occlusion. Reprinted with permissions from Landsman et. al. [2] 
 
 
1.4 Sterilization of SMP foams 
Preliminary efforts have focused on device fabrication and functionality [11] 
[10], but other hurdles must be overcome to realize the clinical potential of these SMP-
based devices; namely, a validated sterilization method is required to gain regulatory 
approval [34] [35] [36] [37] [38] [39]. 
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The proposed thermoset polyurethanes have excellent shape memory capacity 
due to their extensive crosslinking [40], but chain-chain hydrogen bonding influences 
the temperature at which these polymers actuate (Figure 1.5 A). Disruption of this 
hydrogen-bonding network can occur via plasticizers, the most common of which is 
water [8]. In the case of stimuli-responsive polymers, plasticization can drastically 
reduce the actuation temperature at which shape recovery occurs [8] (Figure 1.5 B). The 
shape memory property of these foams is dependent upon a combination of moisture 
plasticization and thermal actuation from heating to body temperature [8] [10] [11]. 
Premature actuation could lead to the polymer system expanding within the delivery 
catheter and subsequent failure of the medical device [8] [10] [11]. Thus, a major hurdle 
for medical device approval is sterilization of this heat and moisture sensitive polymer 
system while minimizing the chance of premature actuation. 
 
 
 
Figure 1.5: A) Molecular example of hydrogen bonding between two polyurethane backbones  
B) Effect of moisture plasticization on polymer modulus versus temperature 
A B 
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There are a number of methods available for sterilization of an implantable 
medical device [35] [41] [42] [43]. This research explores three potential sterilization 
methods for the polyurethane SMP embolic foams: non-traditional ethylene oxide 
(ntEtO) gas sterilization [11], gamma beam irradiation, and electron beam irradiation 
(ebeam).  
 
 1.3.1 Non-Traditional Ethylene Oxide  
Ethylene oxide (EtO) gas sterilization requires gaseous diffusion into the 
packaging in order for the bactericidal, sporicidal, and virucidal gas to interact with the 
microbes on the device [43]. Packaging with gas permeable films segments, such as foil 
header pouches, is necessary for effective EtO sterilization. These gas permeable 
segments, or headers, enable gas and moisture diffusion into the pouch for effective 
sterilization and subsequent EtO off-gassing. Moisture is important for effectively killing 
desiccated bacterial spores during sterilization, and residual EtO must be effectively 
removed prior to device implantation [43]. EtO gas is highly flammable and potentially 
hazardous for patients and sterilization handlers [41]. For safety reasons, porous 
materials are required to aerate for at least 48 hours after EtO sterilization [43]. NtEtO 
differs from EtO sterilization in that it has lower heat and humidity requirements to 
achieve sterility.  
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 1.3.2 Gamma Beam Irradiation 
Gamma beam irradiation sterilizes medical devices by penetrating packaging and 
destroying the covalent bonds of DNA strands and other important biomolecules [44]. 
The primary source of gamma rays is cobalt 60, which emits gamma rays during decay 
and is generally considered a cold method (no increase in temperature is required) [44] 
[45]. Gamma radiation is a safe, reliable method of sterilization but has been shown to 
enhance material degradation and therefore may not be useful for some polymer-based 
medical devices [42] [45] [46] . Due to the generation of oxidative radicals during 
ionization that can potentially lead to material degradation, the packaging plays a crucial 
role in post-sterilization material properties.  
 
 1.3.3 Electron Beam Irradiation 
Ebeam radiation uses an electron linear accelerator to shower devices with 
ionizing radiation to sterilize the devices in a similar manner to gamma radiation but 
with a quicker turnaround time [47]. Ebeam requires less exposure time due to the higher 
dosing rate, leading to reduced potential polymer degradation [46]. Increased available 
energy, improved reliability, and absence of a source that steadily depletes over time are 
additional advantages to the use of ebeam sterilization [45]. A major limitation of ebeam 
sterilization is its reduced penetration and density-dependent gradient within the medical 
device [46]. Nitrogen purged, vacuum-sealed foil pouches are used to limit oxygen and 
moisture diffusion in the packaging that could cause polymer oxidation during 
irradiation.  
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1.5 Summary of thesis 
A validated sterilization method is required for clinical translation of both the 
neurovascular aneurysm occlusion device as well as the Impede ™ peripheral occlusion 
device. The goal of this thesis is to explore the material characteristics of SMP foams 
and foam devices before and after sterilization and make a final recommendation for a 
sterilization method to be used in commercialization.  
Chapter II discusses the materials and methods of SMP foam synthesis and 
characterization that were undertaken. Sterilized foam samples were characterized using 
tensile testing, differential scanning calorimetry, unconstrained cylindrical expansion, 
and Fourier transform infrared (FTIR) spectroscopy. The methods of analysis are 
presented.  
Chapter III presents the results from material characterization before and after 
sterilization. This work was done in an effort to assess the effects of three 
aforementioned sterilization methods on final device performance. 
Chapter IV provides a brief summary of results as well as a discussion of future 
works. A final recommendation for a sterilization method for device commercialization 
is given.  
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CHAPTER II 
METHODS AND MATERIALS2 
 
2.1 Materials 
N,N,N’,N’-tetrakis(2-hydroxypropyl)ethylenediamine (HPED, 99%; Sigma-
Aldrich Inc., St. Louis, MO), triethanolamine (TEA, 98%; Sigma-Aldrich Inc., St. Louis, 
MO), trimethyl-1,6-hexamethylene diisocyanate, 2,2,4- and 2,4,4-mixture (TMHDI; TCI 
America Inc., Portland, OR), hexamethylene diisocyanate (HDI; TCI America Inc., 
Portland, OR), DC 198 (Air Products and Chemicals Inc., Allentown, PA), DC 5943 
(Air Products and Chemicals Inc., Allentown, PA), T-131 (Air Products and Chemicals 
Inc., Allentown, PA), BL-22 (Air Products and Chemicals Inc., Allentown, PA), Enovate 
245fa Blowing Agent (Honeywell International Inc., Houston, TX), 2-propanol 99% 
(IPA) (VWR, Radnor, PA) and deionized (DI) water (E-Pure water system, Barnstead 
International, Dubuque, IA) were used as received.  
 
2.2 Foam Synthesis 
Three different SMP foam formulations, shown in Table 2.1, were synthesized 
using the three-step protocol previously described by Hasan et al. [48, 49]. Briefly, 
isocyanate (NCO) pre-polymers were synthesized using appropriate molar ratios of 
HPED, TEA, TMHDI, and HDI, with a 35 wt % hydroxyl (OH) composition. A OH 
                                                
2 Parts of this chapter are from “Effects	 of	 Sterilization	 on	 Shape	 Memory	 Polyurethane	Embolic	 Foam	 Devices”	 by	 R.	 Muschalek,	 Nash	 L.D.,	 Jones	 R,	 Hasan	 S.M.,	 Keller	 B.K.,	Monroe	M.B.,	Maitland	D.J., which is under review by the Journal of Medical Devices. 
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mixture was prepared with the remaining molar equivalents of HPED and TEA, along 
with catalysts, surfactants, and DI water. During foam blowing, a physical blowing 
agent, Enovate, was mixed with the isocyanate pre-polymer and the OH mixture using a 
speed-mixer (FlakTek Inc., Hauschild, Germany). The resulting foams were cured in a 
vacuum oven (Cascade Tek, Hillsboro, Oregon) at 90 °C for 20 minutes. The SMP 
foams were cooled to room temperature (21 ± 1 °C) followed by a 24-hour cold cure (21 
± 1 °C) before further processing. 
 
Table 2.1: Monomer ratios used in foam synthesis and final cylindrical device diameters 
used in testing (based on foam compositions required for each device prototype) 
Formulation 
Name 
Isocyanate 
(NCO) 
HPED 
(molar eq.) 
TEA 
(molar eq.) 
Cylindrical 
Diameter (mm) 
100TMH60 TMHDI 60 40 1 
100HDIH40 HDI 40 60 8 
100HDIH60 HDI 60 40 6 
 
 
2.3 Cleaning 
Foams were cut into 2 mm slices using a resistively-heated wire cutter (Proxxon 
Thermocut, Prox-Tech Inc., Hickory, NC). The foam slices were shaped using a 
calibrated and certified ASTM Die D- 638 Type IV dog bone punch (Pioneer-Dietecs 
Corporation, Weymouth MA). Samples were then submerged in 1000 mL jars filled with 
IPA and sonicated for 2 x 15 minutes, refreshing the IPA between cycles. Reverse 
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osmosis (RO) water was used as a final wash for 15 minutes under sonication. Samples 
were removed, allowed to air dry, and then dried at 100 °C under vacuum for 12 hours.  
 
2.4 Packaging 
Samples designated for sterilization were packaged in various sizes of foil header 
pouches (Tyvek Foil Pouches, Beacon Converters, Saddle Brooke NJ) using an AVN 
packaging system (AmeriVacS, San Diego, CA). Pouches were purged with nitrogen 
prior to vacuum sealing with heat. Included in all packages were a temperature indicator 
(S-6710 Telatemp Heat Indicator, Uline, Pleasant Prairie, WI) and a humidity indicator 
(S-8028 10 - 60% Humidity Indicator, Uline, Pleasant Prairie, WI). Dog bone SMP 
samples were secured inside the package using adhesive and wire. Cylindrical samples 
were attached with adhesive on each end. Samples designated for gas-based sterilization 
were sealed above a header that allowed gaseous exchange during sterilization and 
degassing. The headers were then sealed and removed to limit further moisture diffusion. 
Samples designated for radiation-based sterilization were completely vacuum-sealed 
within the foil portion of the pouch to prevent ambient oxygen from entering the pouch. 
It should be noted that gamma radiation samples were packaged prior to receipt 
of the AVN packaging system and were not nitrogen purged or vacuum-sealed. This 
discrepancy may have had an impact on the results found and is noted in the discussion.  
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2.5 Sterilization 
The ntEtO samples were sterilized with 10.5 g ± 5% of EtO gas with ambient 
humidity at 30 °C for at least 12 hours at Andersen Scientific (Morrisville, NC). A 
biological indicator strip was placed inside the chamber by Anderson Scientific to ensure 
sterility of the ntEtO samples. Gamma radiation dog bone samples received 40 kGy (25 
kGy + Safety Factor of 1.6) at a Sterigenics sterilization facility [36] [42]. Ebeam 
radiation samples received 40 kGy (25 kGy + Safety Factor of 1.6) at the National 
Center for Electron Beam Research (College Station, TX). A second series of ebeam 
testing was undertaken at 25 kGy [37]. 
 
2.6 Characterization 
2.6.1 Differential scanning calorimetry (DSC) 
Foam samples (2-6 mg) were used for glass transition temperature (Tg) analysis 
using a Q-200 dynamic scanning calorimeter (DSC) (TA Instruments, Inc. New Castle, 
DE) to obtain wet and dry thermograms for the foams. Dry samples were stored in a 
desiccated container and hermetically sealed into aluminum pans. The first cycle 
consisted of decreasing the temperature to -40 °C at 10 °C·min-1 and holding it 
isothermally for 2 minutes. The temperature was then increased to 120 °C at 10 °C·min-1 
and held isothermally for 2 minutes. In the second cycle, the temperature was reduced to 
-40 °C at 10 °C·min-1, held isothermally for 2 minutes, and raised to 120 °C at 10 
°C·min-1. Tg was recorded from the second cycle based on the inflection point of the 
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thermal transition curve using TA instruments software. The aluminum tins were vented 
during this process. Each dry composition was measured at least three times.  
Wet samples were prepared by allowing small foam samples to plasticize in 50 
°C RO water for at least 10 minutes. Water was then pressed out using a mechanical 
press, and samples were tested on a cycle that decreased the temperature to -40 °C at 10 
°C·min-1 and holding it isothermally for 2 minutes. The temperature was then increased 
to 80 °C at 10 °C·min-1. Tg was recorded from the heating cycle as the inflection point 
on the thermal transition curve. Each wet composition was measured at least three times.  
 
2.6.2 Mechanical testing 
Each end of the dog bone foam samples was attached to mechanical testing 
wooden stubs using clear epoxy adhesive and allowed to dry overnight under vacuum. 
Samples were then strained to failure using an Insight 30 material tester (Materials 
Testing Solutions, MTS Systems Corporation, Eden Prairie, MN). Stress versus strain 
curves were analyzed for ultimate tensile stress (UTS) and % strain at break. Each 
composition was tested at least six times.  
 
2.6.3 Crimp diameter 
Foam cylinders (1-8 mm in diameter) were crimped around a nitinol backbone 
wire. Diameters for each foam cylinder were chosen according to clinical applicability 
(Table 2.1). Samples were placed inside the heated chamber of a stent crimper (100 °C) 
(Machine Solutions Inc., Flagstaff, AZ) and allowed to equilibrate for 10 minutes. 
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Crimpers were closed and cooled using room temperature air. Images were taken on a 
Jenoptik Microscope Camera (Jenoptik, Jena, Germany) 24 hours after crimping to 
generate a baseline of device diameter prior to sterilization. ImageJ (NIH, Bethesda, 
MD) processing software was used to quantify the device diameters prior to sterilization. 
Upon receipt of devices after ntEtO and ebeam sterilization, images were taken again, 
and device diameter was re-measured. Any device expansion due to plasticization or 
process-related heating was noted. Each composition was measured at least three times.  
 
2.6.4 Unconstrained expansions 
Unconstrained expansion of cylindrical samples was assessed in a hot water bath 
to obtain actuation profiles after ntEtO and ebeam sterilization. Devices were placed on 
a fixture and submerged in a 37 °C hot water bath. Images were taken with a digital 
camera (PowerShot SX230 HS, Canon Inc., Tokyo, Japan) every thirty seconds for 15 
minutes and analyzed with ImageJ processing software to quantify device diameter over 
time. Each composition was measured three times.  
 
2.6.5 Fourier transform infrared (FTIR) spectroscopy 
Before and after ebeam irradiations, foam samples were cut to 2-3 mm thick, and 
the FTIR spectra were collected using Bruker ALPHA Infrared Spectrometer (Bruker, 
Billerica, MA). Thirty-two background scans of the empty chamber were taken followed 
by sixty-four sample scans of the various foam compositions. FTIR spectra were 
collected in absorption mode at a resolution of 4 cm-1. OPUS software (Bruker, Billerica, 
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MA) was utilized to subtract the background scans from the spectra, to conduct a 
baseline correction for IR beam scattering, and to normalize multiple spectra to one 
another. Each composition was measured three times, and one representative spectrum 
was chosen to display.  
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CHAPTER III 
RESULTS3 
 
3.1 Results 
For the majority of the testing, the most and least hydrophilic foam compositions 
(100HDIH40 and 100TMH60, respectively) were selected for characterization. Further 
classification of ebeam radiation effects was also carried out on 100HDIH60 foams 
(mid-range hydrophilicity) with multiple radiation doses (25 kGy and 40 kGy).  
 
3.2 Differential scanning calorimetry (DSC) 
The results of the Tg analysis are shown in Figure 3.1 A-D. Thermal analysis 
revealed the largest change in dry Tg for ntEtO-sterilized samples (39% change between 
control and sterilized sample). Ebeam and gamma sterilization produced consistent 
thermal behavior for all foam compositions and thermal tests. The thermograms of wet 
DSC measurements for 100HDIH40 foams (Figure 3.1 D) were difficult to read due to 
the proximity of the Tg to the recrystallization peak of water at 0 °C [50]. Thus, these 
results were not considered to be reliable indications of the effects of sterilization.  
                                                
3 Parts of this chapter are from “Effects	 of	 Sterilization	 on	 Shape	 Memory	 Polyurethane	Embolic	 Foam	 Devices”	 by	 R.	 Muschalek,	 Nash	 L.D.,	 Jones	 R,	 Hasan	 S.M.,	 Keller	 B.K.,	Monroe	M.B.,	Maitland	D.J., which is under review by the Journal of Medical Devices. 
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Figure 3.1: Tg measurements for the two foam compositions (A and B: 100TMH60; C and D: 
100HDID40) in dry (A and C) and wet (B and D) conditions. N = 3, average ± standard deviation 
displayed.  
 
 
 
3.3 Mechanical testing 
Figure 3.2 and Figure 3.3 give the ultimate tensile strength (UTS) and strain at 
break, respectively, for each foam composition before and after sterilization. The large 
standard deviations arise from the intrinsic properties of the gas blown foam due to the 
inhomogeneous pore size and shape. No statistically significant differences in UTS or 
strain at break were seen following the three sterilization methods for either composition 
(p < 0.05). 
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Figure 3.2: UTS of a) 100TMH60 and b) 100HDIH40 foams. No significant changes were seen before 
and after sterilization. N = 6, average ± standard deviation displayed.  
 
 
 
Figure 3.3: Strain at break of a) 100TMH60 and b) 100HDIH40 foams. No significant changes were 
seen before and after sterilization. N = 6, average ± standard deviation displayed. 
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3.4 Crimp diameter 
 Yellowing of the gamma irradiated foam samples was observed, and at this point 
gamma was no longer pursued as a potential sterilization method due to hypothesized 
oxidative radicals that threatened to expedite bulk polymer degradation [51].  
The results of the crimp diameter tests can be seen in Figure 3.4 and Tables 3.1 
and 3.2. Some relaxation of the crimp is expected to occur, as seen in the control 
samples, which were left in a dry box for 1 week [52]. It should be noted that “N/A” for 
ntEtO in the 100HDIH40 samples indicates expansion beyond the constraints of the 
packaging that prevented imaging of final devices. Ebeam-sterilized cylinders expanded 
the least, indicating minimal process plasticization; thus, ebeam sterilization was chosen 
for further material classification following application of lower radiation dosage.  
 
 
 
Figure 3.4: Cylindrically crimped 1 mm 100TMH60 foam after each method of sterilization. Images 
were taken with a Jenoptic microscope camera and analyzed using ImageJ software for average 
diameter 
ntEtO 
Control 
Ebeam 
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Table 3.1: Cylindrical expansion of 100TMH60 foams following sterilization. N = 7, average ± 
standard deviation displayed.  
Sterilization 
Process 
Initial Diameter 
(in) 
Final Diameter 
(in) 
Change in Diameter 
(in) 
Control 0.0147 ± 0.0008 0.0154 ± 0.0007 0.0007 
ntEtO 0.0145 ±0.0006 0.0163 ± 0.0011 0.0018 
Ebeam (25 kGy) 0.0145 ± 0.0007 0.0158± 0.0004 0.0013 
 
 
 
Table 3.2: Cylindrical expansion of 100HDIH40 foams following sterilization. N = 3, average ± 
standard deviation displayed.  
Sterilization 
Process 
Initial Diameter 
(in) 
Final Diameter 
(in) 
Change in Diameter 
(in) 
Control 0.043 ± 0.007 0.051 ± 0.004 0.008 
ntEtO 0.050 ± 0.002 N/A N/A 
Ebeam (25 kGy) 0.041 ± 0.005 0.041 ±0.001 0.000 
 
 
 
3.5 Unconstrained expansion 
 To more fully characterize ebeam sterilization, a second HDI foam composition 
(100HDIH60) in addition to the two previously characterized foams was exposed to two 
separate radiation doses (25 kGy and 40 kGy) and utilized in further material 
characterization. Unconstrained cylindrical expansion of ebeam-sterilized samples can 
be seen in Figure 3.5 A-C. Both of the HDI compositions (100HDIH40 and 
100HDIH60) were fully expanded to their original diameters (8 mm for 100HDIH40 and 
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6 mm for 100HDIH60) within 10 minutes, while the TMDHI composition (100TMH60) 
did not achieve full recovery (1 mm) after 30 minutes of testing. The 100TMH60 foam 
exhibited faster expansion after exposure to radiation at both doses as compared to 
control (Figure 3.5 A), while the 100HDIH40 and 100HDIH60 both exhibited slower 
expansion with increasing radiation dose (Figures 3.5 B, C). The most likely cause of 
this discrepancy is the cylindrical size of the prototype devices. The 1 mm 100TMH60 
devices are much smaller than the 8 and 6 mm 100HDIH40 and 100HDIH60 devices, 
respectively. This smaller diameter makes changes more difficult to observe, and the 
100TMH60 foam expansion profiles are all within the same standard deviation range. 
Thus, using larger diameter samples and/or increasing the sample size would most likely 
produce more similar effects to those of the two larger diameter devices.  
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Figure 3.5: Unconstrained expansion over time of exposure to 37°C water for ebeam sterilized (a) 
100TMH60, (b) 100HDIH40, and (c) 100HDIH60 foams. N = 3, average ± standard deviation 
displayed. Dotted line indicates initial cut diameter dimensions. 
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3.6 Fourier transform infrared (FTIR) spectroscopy 
FTIR was used to detect any molecular differences that may have arisen during 
ebeam radiation on the three foam compositions. Selected FTIR spectral regions for the 
foam compositions can be seen in Figure 3.6. No noticeable differences were 
immediately detected between the control compositions and the ebeam sterilized 
compositions, indicating that radiation did not induce a significant molecular change in 
the foam samples. A potential expected change in spectra included oxidative degradation 
of the tertiary amine [42] which could be seen by an increase in the absorbance at 3400, 
indicating an increased –NH stretch post-sterilization [53] 
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Figure 3.6: FTIR spectra of (a) 100TMH60, (b) 100HDIH40, and (c) 100HDIH60 before and after 
ebeam sterilization.  
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CHAPTER IV 
CONCLUSIONS AND FUTURE WORK4 
 
4.1 Summary 
SMP foams show promise for a variety of endovascular treatments because of 
their high shape recovery, porosity, and tunable transition temperature. Prior to this 
work, the effects of sterilization methods on polyurethane SMP foam properties SMP-
based device functionality were unknown [39]. The FDA requires that all implantable 
medical devices undergo sterility assurance testing prior to submission of a premarket 
notification or premarket applications [54]. As a precursor to sterility assurance testing, 
one of many sterilization methods must be selected as the final sterilization method for 
SMP-based medical devices. To address this issue, in this work, SMP foam material 
properties were tested before and after three common sterilization methods: gamma 
radiation, ntEtO, and ebeam radiation.  
In Chapter II, the testing protocol was laid out for bulk material analysis as well 
as device functionality testing. All samples underwent DSC experiments to assess 
thermal changes induced in the foams due to sterilization processes. All samples also 
underwent mechanical tensile testing to failure to look at ultimate tensile strength and 
strain at break to see if any of the sterilization methods changed mechanical properties of 
the foam, which could have affected device functionality. NtEtO and ebeam samples 
                                                
4 Parts of this chapter are from “Effects	 of	 Sterilization	 on	 Shape	 Memory	 Polyurethane	Embolic	 Foam	 Devices”	 by	 R.	 Muschalek,	 Nash	 L.D.,	 Jones	 R,	 Hasan	 S.M.,	 Keller	 B.K.,	Monroe	M.B.,	Maitland	D.J., which is under review by the Journal of Medical Devices. 
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continued in testing at this point with device prototypes being imaged before and after 
sterilization to see if the shape memory effect caused device expansion. Finally, the 
unconstrained expansion profiles and FTIR spectra of ebeam device prototypes were 
obtained to radiation altered shape memory properties or bulk molecular structure.  
It was found that ntEtO-sterilized devices had significant moisture plasticization 
as compared to the two radiation sterilization methods tested. No statistically significant 
changes in mechanical properties were found for any sterilization method tested. 
Minimal device expansion due to sterilization method was seen for ebeam compared to 
ntEtO, which actually caused device failure in one of the foam compositions tested. 
Ebeam samples were tested for unconstrained expansion, and it was found that 
expansion time of the SMP increased with increasing radiation dose. Finally, ebeam 
samples were tested using FTIR to test for oxidative radicals that threaten the durability 
of the polymers long-term in vivo [51].  
In conclusion, it was found that ebeam sterilized SMPs were the most functional 
after sterilization as compared to ntEtO sterilization and gamma radiation sterilization. 
The results from this study are critical to the clinical realization of SMP foam-based 
devices by identifying a reliable sterilization method for future pre-clinical safety and 
efficacy studies [38] [39].   
 
4.2 Discussion 
The goal of this study was to identify and characterize a sterilization method that 
would not disrupt the functionality of a SMP foam-based medical device. In addition to 
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the tested methods, traditional ethylene oxide (EtO) is another common sterilization 
option for medical devices [41]. Due to the failure of the ntEtO-tested foam cylinders as 
noted by the large decrease in Tg, traditional EtO, which is a higher-heat, higher-
humidity process, was removed as a potential sterilization method. Gamma radiation 
should be further investigated in future manuscripts due to the discrepancies that arose in 
packaging, which have significant impact on the potential for oxidative degradation [42] 
[46]. Ebeam radiation showed the most promise for SMP-based medical devices. Ebeam 
sterilization resulted in consistent properties between control foams and sterilized foams. 
Further characterization of electron beam sterilized foams indicated that no significant 
molecular changes occur during sterilization. NtEtO-sterilized foams appeared to have 
been moisture-plasticized during sterilization, as evidenced by a reduced Tg and 
increased diameter that prevented expansion characterization. This result is likely due to 
the relatively long exposure to the  humidity (30%) in ntEtO in the moisture-permeable 
packaging. Ebeam-sterilized  devices retained similar expansion profiles to controls with 
varied dosages and foam compositions. Volume expansion and working time are two of 
the most important functional considerations for SMP foam devices, as they define how 
effective a foam will be at shape-filling a defect site and how long a clinician has to 
deliver the device through the catheter before it expands and restricts delivery of the 
device, respectively. Maintenance of device functionality following sterilization  is 
essential in successfully obtaining FDA clearance. Further characterization of  electron 
beam sterilized foams indicated that no significant molecular changes  occur during 
sterilization. Oxidation is a large concern for SMP foams, as it could  alter long-term 
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stability and performance. Thus, a reduced potential of oxidation following ebeam 
sterilization is highly promising for SMP foam-based medical  device development. 
 
4.3 Challenges and future work 
Challenges of this work include the discrepancies seen in unconstrained 
expansion testing of the SMP foam cylinders. While the 100TMH60 foams appeared to 
expand more quickly with ebeam radiation, the 100HDIH40 and 100HDIH60 foams 
appeared to expand more slowly with radiation. It was hypothesized that two variables 
were confounding the final results of the expansions, namely: crosslinking 
rearrangement and surface oxidation. Further characterization of these two phenomena 
should be pursued because preliminary studies of each (using dynamic mechanical 
analysis or DMA, and attenuated total reflectance Fourier transform infrared 
spectroscopy or ATR-FITR) were inconclusive. A series with a single sample of each 
radiation dose in the DMA found that minimal crosslinking rearrangement was 
occurring. Preliminary ATR-FTIR data found that with ebeam radiation at high doses 
(60 kGy) and neat films packaged in ambient air, surface oxidation was occurring as 
seen by the generation of an amine-oxide peak at 950 cm-1 [55].  
The work that should be completed next is sterility assurance testing [54]. This 
work encompassed both radiation doses that are typically utilized for sterility testing, but 
a verification of sterilization is required for future device translation. The most common 
method of sterility assurance testing is called “Verification of Dose Maximum (VDmax) 
and entails a three step process of: (1) A bioburden test to quantify the viable 
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microorganisms on or in the product. This test is performed prior to any sterilization but 
after all other manufacturing steps including packaging, (2) An application of 
verification dose where the bioburden results are taken to a table from the standard (ISO 
11137) to determine the proper verification dose. The verification dose is then applied to 
the required number of products. In the particular case of our SMP-based embolic 
devices the required radiation dose is most likely substantially lower than the doses 
tested herein because the research was attempting to assess the effects of the highest 
doses of radiation on the medical devices (3) A sterility test where irradiated products 
undergo a test of sterility including biological indicators. This takes into account a 
bacteriostasis/ Fugistasis test to demonstrate the lack of inhibition in the sterility test 
system and is required to validate sterility test.  
Secondarily, gamma radiation sterilization could be re-visited as a potential for 
sterilization of SMP-based foam devices if correct packaging environments could be 
generated. There is still the concern of core wire heating due to gamma radiation, which 
could induce premature thermal actuation of the devices.  
Finally, other researchers at the University of Texas at Dallas [38] suggest the 
use of 254 nm wavelength UV light for 120 minutes as another mode of plausible 
sterilization for SMP-based devices. This method should be investigated for any effects 
on polyurethane SMP foam expansion times.   
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